| 000 | 01577 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513034704.0 | ||
| 264 | 0 | _c19950914 | |
| 008 | 199509s 0 0 eng d | ||
| 022 | _a1073-449X | ||
| 024 | 7 |
_a10.1164/ajrccm.152.2.7633726 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHussain, S N | |
| 245 | 0 | 0 |
_aRole of nitric oxide in endotoxin-induced metabolic and vascular dysregulation of the canine diaphragm. _h[electronic resource] |
| 260 |
_bAmerican journal of respiratory and critical care medicine _cAug 1995 |
||
| 300 |
_a683-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArginine _xadministration & dosage |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCardiac Output _xdrug effects |
| 650 | 0 | 4 |
_aDiaphragm _xblood supply |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aEndotoxins _xadverse effects |
| 650 | 0 | 4 | _aEscherichia coli |
| 650 | 0 | 4 |
_aHypotension _xmetabolism |
| 650 | 0 | 4 | _aInfusions, Intra-Arterial |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aNG-Nitroarginine Methyl Ester |
| 650 | 0 | 4 |
_aNitric Oxide _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOxygen Consumption _xdrug effects |
| 650 | 0 | 4 | _aRegional Blood Flow |
| 650 | 0 | 4 |
_aShock, Septic _xmetabolism |
| 650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
| 650 | 0 | 4 | _aVasodilation |
| 773 | 0 |
_tAmerican journal of respiratory and critical care medicine _gvol. 152 _gno. 2 _gp. 683-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1164/ajrccm.152.2.7633726 _zAvailable from publisher's website |
| 999 |
_c7633164 _d7633164 |
||